Aquaflor® Type A Medicated Article
In catfish, Aquaflor (florfenicol) is approved for the control of mortality due to enteric septicemia (ESC) associated with Edwardsiella ictaluriand columnaris disease associated with Flavobacterium columnare.*
Broad-spectrum antibiotic with unique molecular structure
Proprietary formulation developed specifically for aquaculture
Keeps fish healthy, so they stay on feed for optimum survival, growth and returns
Reduces mortality so you can produce more fish
Studies show that fish readily consume feed with Aquaflor - palatability comparable to unmedicated feed
Minimize wasted feed, maximize antibiotic uptake
Uniform granulation for optimum distribution in feed and more accurate dosage delivery
Now approved for all freshwater-reared finfish with more indications
- Can be fed from fingerlings to food fish
May be used in sinking or floating feeds
Stable under high-temperature extrusion processes
Single withdrawal time (15 days) for all species and indications at dose rates of up to 15 mg/kg
No adverse effects on fish behavior or performance, even when tested at 5X and 10X dose rates1
- Developed specifically for fish and food-animal species - not used in human medicine
Friendly to environment - no significant risk to aquatic ecosystems
1See Product Bulletin for more details.
*AQUAFLOR also may be used in other freshwater-reared finfish for the control of mortality due to columnaris disease associated with Flavobacterium columnare.
CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Copyright ©2015 Intervet Inc., a subsidiary of Merck & Co., Inc. All rights reserved.
Studies show Aquaflor has no negative impact on mortality, behavior or feed consumption - even when fed at 10 times the recommended dose rate.